Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

What is behind the non-antibiotic properties of minocycline?

Garrido-Mesa N, Zarzuelo A, Gálvez J.

Pharmacol Res. 2013 Jan;67(1):18-30. doi: 10.1016/j.phrs.2012.10.006. Epub 2012 Oct 17. Review.

PMID:
23085382
2.

Minocycline: far beyond an antibiotic.

Garrido-Mesa N, Zarzuelo A, Gálvez J.

Br J Pharmacol. 2013 May;169(2):337-52. doi: 10.1111/bph.12139. Review.

3.

The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties.

Garrido-Mesa N, Camuesco D, Arribas B, Comalada M, Bailón E, Cueto-Sola M, Utrilla P, Nieto A, Zarzuelo A, Rodríguez-Cabezas ME, Gálvez J.

Pharmacol Res. 2011 Apr;63(4):308-19. doi: 10.1016/j.phrs.2010.12.011. Epub 2010 Dec 28.

PMID:
21193045
4.

Minocycline and neurodegenerative diseases.

Kim HS, Suh YH.

Behav Brain Res. 2009 Jan 23;196(2):168-79. doi: 10.1016/j.bbr.2008.09.040. Epub 2008 Oct 11. Review.

PMID:
18977395
5.

Minocycline and cytoprotection: shedding new light on a shadowy controversy.

Jordan J, Fernandez-Gomez FJ, Ramos M, Ikuta I, Aguirre N, Galindo MF.

Curr Drug Deliv. 2007 Jul;4(3):225-31. Review.

PMID:
17627496
6.

Minocycline for short-term neuroprotection.

Elewa HF, Hilali H, Hess DC, Machado LS, Fagan SC.

Pharmacotherapy. 2006 Apr;26(4):515-21. Review.

7.

The role of minocycline in ischemia-reperfusion injury: a comprehensive review of an old drug with new implications.

Ulgen BO, Field MG, Qureshi W, Knight RA, Stephanou A, Latchman DS, Vasquez D, Barry SP, Saravolatz L 2nd, Scarabelli GM, Faggian G, Mazzucco A, Saravolatz L, Chen-Scarabelli C, Scarabelli TM.

Recent Pat Cardiovasc Drug Discov. 2011 May;6(2):123-32. Review.

PMID:
21599619
8.

Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation.

Tikka T, Usenius T, Tenhunen M, Keinänen R, Koistinaho J.

J Neurochem. 2001 Sep;78(6):1409-14.

9.

Anti-apoptotic and anti-oxidative mechanisms of minocycline against sphingomyelinase/ceramide neurotoxicity: implication in Alzheimer's disease and cerebral ischemia.

Chen SD, Yin JH, Hwang CS, Tang CM, Yang DI.

Free Radic Res. 2012 Aug;46(8):940-50. doi: 10.3109/10715762.2012.674640. Epub 2012 May 28. Review.

PMID:
22583533
10.

Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action.

Griffin MO, Ceballos G, Villarreal FJ.

Pharmacol Res. 2011 Feb;63(2):102-7. doi: 10.1016/j.phrs.2010.10.004. Epub 2010 Oct 14. Review.

11.

Is Minocycline an Antiviral Agent? A Review of Current Literature.

Nagarakanti S, Bishburg E.

Basic Clin Pharmacol Toxicol. 2016 Jan;118(1):4-8. doi: 10.1111/bcpt.12444. Epub 2015 Aug 2. Review.

12.

In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).

Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT.

Antimicrob Agents Chemother. 1999 Apr;43(4):738-44.

13.

Minocycline: a bacteriostatic antibiotic with pleiotropic cardioprotective effects.

Brenes-Salazar JA.

Can J Physiol Pharmacol. 2015 Oct;93(10):863-6. doi: 10.1139/cjpp-2014-0493. Epub 2015 Apr 17. Review.

PMID:
26382908
14.

Clinical potential of minocycline for schizophrenia.

Miyaoka T.

CNS Neurol Disord Drug Targets. 2008 Oct;7(4):376-81. Review.

PMID:
18991666
15.

Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.

Garrison MW, Neumiller JJ, Setter SM.

Clin Ther. 2005 Jan;27(1):12-22. Review.

PMID:
15763603
16.

Tigecycline: a glycylcycline antimicrobial agent.

Doan TL, Fung HB, Mehta D, Riska PF.

Clin Ther. 2006 Aug;28(8):1079-106. Review.

PMID:
16982286
17.

Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons.

Lin S, Zhang Y, Dodel R, Farlow MR, Paul SM, Du Y.

Neurosci Lett. 2001 Nov 23;315(1-2):61-4.

PMID:
11711215
18.

Tigecycline - how powerful is it in the fight against antibiotic-resistant bacteria?

Seputiene V, Povilonis J, Armalyte J, Suziedelis K, Pavilonis A, Suziedeliene E.

Medicina (Kaunas). 2010;46(4):240-8. Review.

19.

A novel modified acrylic bone cement matrix. A step forward on antibiotic delivery against multiresistant bacteria responsible for prosthetic joint infections.

Matos AC, Gonçalves LM, Rijo P, Vaz MA, Almeida AJ, Bettencourt AF.

Mater Sci Eng C Mater Biol Appl. 2014 May 1;38:218-26. doi: 10.1016/j.msec.2014.02.002. Epub 2014 Feb 12.

PMID:
24656372
20.

Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death.

Ossola B, Lantto TA, Puttonen KA, Tuominen RK, Raasmaja A, Männistö PT.

J Neurosci Res. 2012 Mar;90(3):682-90. doi: 10.1002/jnr.22791. Epub 2011 Nov 23.

PMID:
22108958

Supplemental Content

Support Center